Biomedical nanotechnology and diagnostics
3 European H2020 organizations list this as part of their work.
Most active in this area
- ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING MCGILL UNIVERSITY
Leading Canadian university bridging EU-North American research in genomics, health data infrastructure, and federated cohort governance.
“Partner in Nano-OligoMed (hybrid nanostructured oligonucleotide drug delivery) and IMPED (microfluidic exosome detection for liquid biopsy).”
CA39 projects - POLITECHNIKA WROCLAWSKA
Polish technical university combining advanced materials, photonics, and biomedical nanotech research with hands-on SME innovation support across West Poland.
“Magnetic nanoparticle cancer therapies (NANOCARGO, coordinated), saliva-based biosensors and microfluidic chips (SALSETH), and protease visualization for tumor research (PROVIST, coordinated).”
PL37 projects - AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE
Italian university hospital contributing clinical expertise and patient access to European rare disease and paediatric trial networks.
“Participated in Immuno-NanoDecoder, focused on nanostructured molecular decoders for multiplexed disease detection.”
IT6 projects